Severe Henoch-Schönlein purpura in a thalassemic patient under deferiprone treatment

5Citations
Citations of this article
21Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Herein we present a 7-year-old β-thalassemia major patient who developed severe Henoch-Schönlein purpura (HSP) with renal, pulmonary involvement and invagination while under iron chelation with deferiprone. DNA analysis for familial Mediterranean fever revealed M696V mutation. Various cellular and humoral immunological impairments have been described in thalassemia major patients and the severe course of HSP in our case may be related to these underlying immunological defects. © 2007 Wiley-Liss, Inc.

Cite

CITATION STYLE

APA

Unal, S., Güçer, S., Kale, G., Besbas, N., Özen, S., & Gümrük, F. (2008). Severe Henoch-Schönlein purpura in a thalassemic patient under deferiprone treatment. American Journal of Hematology, 83(2), 165–166. https://doi.org/10.1002/ajh.21052

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free